Optical Genome Mapping for Prenatal Diagnosis in Fetuses With Structural Anomalies
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Yiyun Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, China. Hauptthemen laut MEDLINE: Chromosome Mapping, Prenatal Diagnosis, Chromosome Aberrations. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jiangsu Province Capability Improvement Project through Science, Technology and Education Jiangsu Provincial Medical Key Discipline, National Natural Science Foundation of China, the National Key R&D Program of China.
Abstract (Originalsprache)
Objective
To evaluate the clinical value of optical genome mapping (OGM) for prenatal diagnosis in fetuses with structural anomalies.
Method
OGM was performed prospectively in 204 cases of fetuses with structural anomalies. Detection rates of OGM were investigated. Subgroup analysis was then conducted.
Results
Overall, pathogenic or likely pathogenic (P/LP) chromosome aberrations were identified in 28 (13.7%) fetuses with structural anomalies using OGM, including 12 with numerical chromosomal abnormalities, 14 with P/LP copy number variations (CNVs) and two with balanced chromosomal rearrangements. OGM structural variation (SV) algorithm provided the structure and breakpoint information for 17 SVs and revealed six deletions, six tandem direct duplications, one inverted duplication, one paired duplication flanking a cryptic inversion and three balanced chromosomal rearrangements (one likely benign and two with breakpoints disrupting OMIM Morbid gene associated with dominant inheritance disorders). The diagnostic yields of OGM in the cystic hygroma group and multisystem malformation group were both significantly higher than those in other groups (35.7% vs. 10.3%, adjusted p = 0.018; 31.3% vs. 10.3%, adjusted p = 0.04).
Conclusion
Our study suggests that OGM is a reliable, comprehensive and high‐resolution technology with an acceptable turnaround time that is a powerful method for prenatal diagnosis in fetuses with structural anomalies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, China.
- Department of Medical Genetics and Prenatal Diagnosis, Lianyungang Maternal and Child Health Hospital, Lianyungang, China.
ORCID-Profile: Zhengfeng Xu
Förderung
- Jiangsu Province Capability Improvement Project through Science, Technology and Education Jiangsu Provincial Medical Key Discipline
- National Natural Science Foundation of China
- the National Key R&D Program of China
Zitieren
APA
Xu, Y., Chen, H., Zhang, Q., Tan, J., Zhou, R., Ji, X., Luo, C., Meng, L., Liu, A., Wang, Y., Hu, P., & Xu, Z. (2025). Optical Genome Mapping for Prenatal Diagnosis in Fetuses With Structural Anomalies. Prenatal Diagnosis. https://doi.org/10.1002/pd.6798
Vancouver
Xu Y, Chen H, Zhang Q, Tan J, Zhou R, Ji X, et al. Optical Genome Mapping for Prenatal Diagnosis in Fetuses With Structural Anomalies. Prenatal Diagnosis. 2025. doi:10.1002/pd.6798
BibTeX
@article{Xu2025,
author = {Xu, Yiyun and Chen, Hao and Zhang, Qinxin and Tan, Juan and Zhou, Ran and Ji, Xiuqing and Luo, Chunyu and Meng, Lulu and Liu, An and Wang, Yan and Hu, Ping and Xu, Zhengfeng},
title = {Optical Genome Mapping for Prenatal Diagnosis in Fetuses With Structural Anomalies},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6798}
}
EUVIMED